Alan Tyndall

22.2k total citations · 1 hit paper
158 papers, 7.2k citations indexed

About

Alan Tyndall is a scholar working on Pathology and Forensic Medicine, Hematology and Rheumatology. According to data from OpenAlex, Alan Tyndall has authored 158 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pathology and Forensic Medicine, 42 papers in Hematology and 35 papers in Rheumatology. Recurrent topics in Alan Tyndall's work include Systemic Sclerosis and Related Diseases (72 papers), Hematopoietic Stem Cell Transplantation (31 papers) and Mesenchymal stem cell research (30 papers). Alan Tyndall is often cited by papers focused on Systemic Sclerosis and Related Diseases (72 papers), Hematopoietic Stem Cell Transplantation (31 papers) and Mesenchymal stem cell research (30 papers). Alan Tyndall collaborates with scholars based in Switzerland, Italy and United Kingdom. Alan Tyndall's co-authors include Aloïs Gratwohl, Marco Matucci‐Cerinic, Ulrich A. Walker, Chiara Bocelli‐Tyndall, Jacob M. van Laar, Dominique Farge, Thomas Daikeler, Ulf Müller‐Ladner, Christopher P. Denton and Otylia Kowal‐Bielecka and has published in prestigious journals such as The Lancet, Nature Medicine and Blood.

In The Last Decade

Alan Tyndall

153 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

2007 628 citations Ulrich A. Walker, Alan Tyndall et al. Annals of the Rheumatic Diseases profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Alan Tyndall	3.2k	1.6k	1.6k	1.4k	1.4k	158	7.2k
Dominique Farge	3.7k 1.2×	1.8k 1.1×	843 0.5×	1.3k 1.0×	1.1k 0.8×	250	9.1k
David Launay	3.8k 1.2×	1.1k 0.7×	1.7k 1.1×	3.5k 2.5×	1000 0.7×	321	7.8k
Richard M. Silver	4.1k 1.3×	1.1k 0.7×	1.1k 0.7×	2.9k 2.1×	625 0.4×	167	7.1k
Serena Guiducci	4.1k 1.3×	1.5k 0.9×	914 0.6×	1.4k 1.0×	445 0.3×	227	6.4k
Jérôme Avouac	4.9k 1.5×	1.9k 1.2×	2.1k 1.4×	2.2k 1.6×	333 0.2×	253	8.3k
Nicoletta Del Papa	1.4k 0.4×	1.3k 0.8×	2.0k 1.3×	834 0.6×	376 0.3×	138	4.8k
Gabriele Valentini	4.3k 1.3×	1.6k 1.0×	1.8k 1.1×	1.6k 1.1×	200 0.1×	232	6.8k
Raphaèle Séror	1.3k 0.4×	1.1k 0.7×	2.9k 1.9×	1.9k 1.3×	543 0.4×	175	8.5k
Jacques‐Eric Gottenberg	1.0k 0.3×	1.7k 1.1×	2.7k 1.7×	520 0.4×	537 0.4×	163	7.1k
I. Marie	1.3k 0.4×	825 0.5×	1.8k 1.1×	1.5k 1.1×	391 0.3×	171	5.0k

Countries citing papers authored by Alan Tyndall

Since Specialization

Citations

This map shows the geographic impact of Alan Tyndall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Tyndall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Tyndall more than expected).

Fields of papers citing papers by Alan Tyndall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Tyndall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Tyndall. The network helps show where Alan Tyndall may publish in the future.

Co-authorship network of co-authors of Alan Tyndall

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Tyndall. A scholar is included among the top collaborators of Alan Tyndall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Tyndall. Alan Tyndall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maurer, Britta, Nicole Graf, Beat A. Michel, et al.. (2014). Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database. Annals of the Rheumatic Diseases. 74(6). 1124–1131. 87 indexed citations

Hawkey, C J, Matthieu Allez, Sandro Ardizzone, et al.. (2013). OC-014 Clinical and Endoscopic Improvement following Hemopoietic Stem Cell Transplantation vs Mobilisatiion alone in Crohn’S Disease. Gut. 62(Suppl 1). A6.2–A6. 1 indexed citations

Martín, Iván, Helen Baldomero, Chiara Bocelli‐Tyndall, et al.. (2013). The Survey on Cellular and Engineered Tissue Therapies in Europe in 2011. Tissue Engineering Part A. 20(1-2). 4188117601–4188117601. 65 indexed citations

Martín, Iván, Helen Baldomero, Chiara Bocelli‐Tyndall, et al.. (2012). The Survey on Cellular and Engineered Tissue Therapies in Europe in 2010. Tissue Engineering Part A. 18(21-22). 2268–2279. 29 indexed citations

Laar, Jacob M. van, Dominique Farge, Jacob K. Sont, et al.. (2012). LB0002 The astis trial: Autologous stem cell transplantation versus IV pulse cyclophosphamide in poor prognosis systemic sclerosis, first results. Annals of the Rheumatic Diseases. 71. 151–151. 16 indexed citations

Martín, Iván, Helen Baldomero, Chiara Bocelli‐Tyndall, et al.. (2011). The Survey on Cellular and Engineered Tissue Therapies in Europe in 2009. Tissue Engineering Part A. 17(17-18). 2221–2230. 26 indexed citations

Martín, Iván, Helen Baldomero, Alan Tyndall, Dietger Niederwieser, & Aloïs Gratwohl. (2010). A Survey on Cellular and Engineered Tissue Therapies in Europe in 2008. Tissue Engineering Part A. 16(8). 2419–2427. 21 indexed citations

Rovó, Alicia, Thomas Daikeler, Jörg Halter, et al.. (2010). Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica. 96(1). 150–155. 22 indexed citations

Avouac, Jérôme, Ulrich A. Walker, Alan Tyndall, et al.. (2010). Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database. The Journal of Rheumatology. 37(7). 1488–1501. 144 indexed citations

10.

Bocelli‐Tyndall, Chiara, Paul Zajac, Nunzia Di Maggio, et al.. (2010). Fibroblast growth factor 2 and platelet‐derived growth factor, but not platelet lysate, induce proliferation‐dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis & Rheumatism. 62(12). 3815–3825. 77 indexed citations

11.

Spoerl, David, et al.. (2009). Multisegmental spondylitis due to Tropheryma whipplei: Case report. Orphanet Journal of Rare Diseases. 4(1). 13–13. 15 indexed citations

12.

Tyndall, Alan & Antonio Uccelli. (2009). Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Bone Marrow Transplantation. 43(11). 821–828. 82 indexed citations

13.

Matucci‐Cerinic, Marco, Yannick Allanore, László Czirják, et al.. (2009). The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Annals of the Rheumatic Diseases. 68(9). 1377–1380. 106 indexed citations

14.

Tyndall, Alan. (2008). Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases. Transfusion Medicine and Hemotherapy. 35(4). 8–8. 2 indexed citations

15.

Tyndall, Alan & Dominique Farge. (2005). Progress in hematopoietic stem cell transplantation for autoimmune diseases. Expert Review of Clinical Immunology. 1(1). 159–167. 1 indexed citations

16.

Walter, Martin A., R Melzer, Christian Schindler, et al.. (2005). The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. European Journal of Nuclear Medicine and Molecular Imaging. 32(6). 674–681. 244 indexed citations

17.

Tyndall, Alan. (2001). Haematopoietic Stem Cell Transplantation (HSCT) for Severe Autoimmune Disease : An Update of Results and Planned Trials. 41(2). 175–176. 3 indexed citations

18.

Gratwohl, Aloïs & Alan Tyndall. (1997). Hämatopoietische Stammzelltransplantationen in der Behandlung von Autoimmunkrankheiten (Blood or marrow stem cell transplants as treatment for autoimmune disorders). Zeitschrift für Rheumatologie. 56(4). 173–177. 4 indexed citations

19.

Bekkum, D. W. van, Alberto M. Marmont, Alan Tyndall, et al.. (1996). Severe Autoimmune Diseases. Stem Cells. 14(4). 460–472. 12 indexed citations

20.

Plohmann, Andrea M., et al.. (1994). Central nervous system lupus: Concomitant occurrence of myelopathy and cognitive dysfunction. Clinical Rheumatology. 13(2). 273–279. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact